ACMR vs. ETON
ACMR (ACM Research, Inc.) and ETON (Eton Pharmaceuticals Inc) are both stocks. ACMR operates in Semiconductor Equipment & Materials (Technology), while ETON operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, ACMR returned 25.99%/yr vs 36.00%/yr for ETON. At a 0.16 correlation, their price movements are largely independent.
Performance
ACMR vs. ETON - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ACMR achieves a 138.15% return, which is significantly higher than ETON's 86.81% return.
ACMR
- 1D
- 2.45%
- 1M
- 45.10%
- YTD
- 138.15%
- 6M
- 141.95%
- 1Y
- 265.21%
- 3Y*
- 104.60%
- 5Y*
- 25.99%
- 10Y*
- —
ETON
- 1D
- -1.62%
- 1M
- 2.50%
- YTD
- 86.81%
- 6M
- 89.16%
- 1Y
- 117.71%
- 3Y*
- 102.22%
- 5Y*
- 36.00%
- 10Y*
- —
ACMR vs. ETON - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ACMR ACM Research, Inc. | 138.15% | 161.26% | -22.72% | 153.44% | -72.87% | 4.95% | 340.38% | 69.58% | -3.72% |
ETON Eton Pharmaceuticals Inc | 86.81% | 26.95% | 204.11% | 55.32% | -34.27% | -47.23% | 12.92% | 17.65% | -4.23% |
Correlation
The correlation between ACMR and ETON is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Nov 13, 2018 | 0.16 |
Fundamentals
ACMR:
$6.55B
ETON:
$996.57M
ACMR:
$1.33
ETON:
-$0.05
ACMR:
6.71
ETON:
10.20
ACMR:
4.14
ETON:
32.55
ACMR:
$960.23M
ETON:
$86.93M
ACMR:
$424.76M
ETON:
$47.61M
ACMR:
$162.91M
ETON:
$5.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ACMR vs. ETON — Risk / Return Rank
ACMR
ETON
ACMR vs. ETON - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ACM Research, Inc. (ACMR) and Eton Pharmaceuticals Inc (ETON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACMR | ETON | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.27 | ||
| Sortino ratioReturn per unit of downside risk | +0.34 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.36 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 5.76 | 3.27 | +2.49 |
| Martin ratioReturn relative to average drawdown | 14.73 | 6.73 | +7.99 |
Loading charts...
Drawdowns
ACMR vs. ETON - Drawdown Comparison
The maximum ACMR drawdown since its inception was -87.23%, which is greater than ETON's maximum drawdown of -79.94%. Use the drawdown chart below to compare losses from any high point for ACMR and ETON.
Loading charts...
Drawdown Indicators
| ACMR | ETON | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.23% | -79.94% | -7.29% |
Max Drawdown (1Y)Largest decline over 1 year | -46.34% | -36.17% | -10.17% |
Max Drawdown (3Y)Largest decline over 3 years | -58.42% | -45.65% | -12.77% |
Max Drawdown (5Y)Largest decline over 5 years | -84.81% | -70.42% | -14.39% |
Current DrawdownCurrent decline from peak | 0.00% | -9.74% | +9.74% |
Average DrawdownAverage peak-to-trough decline | -39.55% | -37.58% | -1.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.11% | 17.56% | +0.55% |
Volatility
ACMR vs. ETON - Volatility Comparison
ACM Research, Inc. (ACMR) has a higher volatility of 33.26% compared to Eton Pharmaceuticals Inc (ETON) at 17.63%. This indicates that ACMR's price experiences larger fluctuations and is considered to be riskier than ETON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ACMR | ETON | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 33.26% | 17.63% | +15.63% |
Volatility (6M)Calculated over the trailing 6-month period | 59.35% | 40.49% | +18.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.68% | 54.85% | +22.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.77% | 63.41% | +17.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.99% | 63.87% | +20.12% |
Dividends
ACMR vs. ETON - Dividend Comparison
Neither ACMR nor ETON has paid dividends to shareholders.
Financials
ACMR vs. ETON - Financials Comparison
This section allows you to compare key financial metrics between ACM Research, Inc. and Eton Pharmaceuticals Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ACMR vs. ETON - Profitability Comparison
ACMR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ACM Research, Inc. reported a gross profit of 107.24M and revenue of 231.26M. Therefore, the gross margin over that period was 46.4%.
ETON - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported a gross profit of 14.74M and revenue of 24.27M. Therefore, the gross margin over that period was 60.7%.
ACMR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ACM Research, Inc. reported an operating income of 36.18M and revenue of 231.26M, resulting in an operating margin of 15.6%.
ETON - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported an operating income of 2.41M and revenue of 24.27M, resulting in an operating margin of 10.0%.
ACMR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ACM Research, Inc. reported a net income of 17.31M and revenue of 231.26M, resulting in a net margin of 7.5%.
ETON - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported a net income of 1.55M and revenue of 24.27M, resulting in a net margin of 6.4%.
Frequently Asked Questions
ACMR and ETON have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ACMR has higher volatility (33.26%) compared to ETON (17.63%). In terms of maximum drawdown, ACMR dropped -87.23% vs ETON's -79.94%.
ACMR currently has the higher Sharpe Ratio (3.44 vs 2.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ACMR and ETON
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer